Symptom-oriented follow-up of early breast cancer - As good as conventional control and sparing resources

Onkologie

Volumn 30, Issue 8-9, 2007, Pages 410-412

  Khatcheressian, James ^a   Smith, Thomas J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BREAST CANCER; CANCER EPIDEMIOLOGY; CANCER RECURRENCE; DISEASE FREE SURVIVAL; EARLY CANCER; EDITORIAL; EXERCISE; FAT INTAKE; FOLLOW UP; GERMANY; HEALTH CARE PERSONNEL; HOT FLUSH; HUMAN; MEDICAL EXAMINATION; OUTCOME ASSESSMENT; OVERALL SURVIVAL; QUALITY OF LIFE; SYMPTOMATOLOGY; VAGINA ATROPHY; ADULT; BREAST TUMOR; COHORT ANALYSIS; FEMALE; METHODOLOGY; MIDDLE AGED; MORTALITY; NOTE; PROGNOSIS; REPRODUCIBILITY; RISK ASSESSMENT; RISK FACTOR; SENSITIVITY AND SPECIFICITY; SURVIVAL; SURVIVAL RATE; TREATMENT OUTCOME;

ADULT; BREAST NEOPLASMS; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; GERMANY; HUMANS; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); PROGNOSIS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT; RISK FACTORS; SENSITIVITY AND SPECIFICITY; SURVIVAL ANALYSIS; SURVIVAL RATE; TREATMENT OUTCOME;

EID: 35348873092     PISSN: 0378584X     EISSN: None     Source Type: Journal    
DOI: 10.1159/000105331     Document Type: Editorial

References (29)

1. Bornhak S, Heidemann E, Herschlein HJ, Simon W, Merkle E, Widmaier G, Ernst R, Greulich M, Bittner R, Kieninger G, Merkle P, Strosche H, Karg C, Wellhaeußer U, Aulitzky W, Schmidt B, Metzger H, Hahn M et al: Symptom-oriented follow-up of early breast cancer is not inferior to conventional control. Results of a prospective multicenter study. Onkologie 2007;30: DOI: 10.1159/000105257.
2. The GIVIO Investigators: Impact of follow-up testing on survival and health-related quality of life in breast cancer patients: A multicenter randomized controlled trial. JAMA 1994;271:1587-1592.
3. Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S, Pacini P, Distante V: Intensive diagnostic follow-up after treatment of primary breast cancer: A randomized trial - National Research Council Project on Breast Cancer Follow-Up. JAMA 1994;271:1593-1597.
4. Rojas MP, Telaro E, Russo A, Moschetti I, Coe L, Fossati R, Palli D, del Roselli TM, Liberati A: Follow-up strategies for women treated for early breast cancer. Oxford, UK, Cochrane Library 2005;CD001768, 1.
5. Khatcheressian JL, Wolff AC, Smith TJ, Grunfeld E, Muss HB, Vogel VG, Halberg F, Somerfield MR, Davidson NE; American Society of Clinical Oncology. American Society of Clinical Oncology: 2006 update of the breast cancer follow-up and management guidelines in the adjuvant setting. J Clin Oncol 2006;24:5091-5097.
6. Grunfeld E, Dhesy-Thind S, Levine M; Steering Committee on Clinical Practice Guidelines for the Care and Treatment of Breast Cancer: Clinical practice guidelines for the care and treatment of breast cancer: follow-up after treatment for breast cancer (summary of the 2005 update). CMAJ 2005;172:1319-1320.
7. NCCN Guidelines, www.nccn.org/professionals/physician_gls/default. asp.
8. Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ: Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol 2007;25:1074-1081.
9. Edelman MJ, Meyers FJ, Siegel D: The utility of follow-up testing after curative cancer therapy. A critical review and economic analysis. J Gen Intern Med 1997;12:318-331.
10. Montgomery DA, Krupa K, Cooke TG: Alternative methods of follow up in breast cancer: a systematic review of the literature. Br J Cancer 2007;96:1625-1632.
11. Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ: Surveillance testing among survivors of early-stage breast cancer. J Clin Oncol 2007;25:1074-1081.
12. Gion M, Mione R, Leon AE, Lüftner D, Molina R, Possinger K, Robertson JF: CA27.29: a valuable marker for breast cancer management. A confirmatory multicentric study on 603 cases. Eur J Cancer 2001;37:355-363. .
13. Chan DW, Beveridge RA, Muss H, Fritsche HA, Hortobagyi G, Theriault R, Kiang D, Kennedy BJ, Evelegh M: Use of Truquant BR radioimmunoassay for early detection of breast cancer recurrence in patients with stage II and stage III disease. J Clin Oncol 1997;15:2322-2328.
14. Early Breast Cancer Trialists' Collaborative Group (EBCTCG): Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials. Lancet 2005;365:1687-1717.
15. Palli D, Russo A, Saieva C, Ciatto S, Rosselli Del Turco M, Distante V, Pacini P: Intensive vs. clinical follow-up after treatment of primary breast cancer: 10-year update of a randomized trial. National Research Council Project on Breast Cancer Followup. JAMA 1999;281:1586.
16. Hortobagyi GN; American Society of Clinical Oncology: A shortage of oncologists? The American Society of Clinical Oncology workforce study. J Clin Oncol 2007;25:1468-1469.
17. Keating NL, Landrum MB, Guadagnoli E, Winer EP, Ayanian JZ: Factors related to underuse of surveillance mammography among breast cancer survivors. J Clin Oncol 2006;24:85-94.
18. Doubeni CA, Field TS, Ulcickas Yood M, Rolnick SJ, Quessenberry CP, Fouayzi H, Gurwitz JH, Wei F: Patterns and predictors of mammography utilization among breast cancer survivors. Cancer 2006;106:2482-2488.
19. Grunfeld E, Mant D, Yudkin P, Adewuyi-Dalton R, Cole D, Stewart J, Fitzpatrick R, Vessey M: Routine follow up of breast cancer in primary care: randomised trial. BMJ 1996;313:665-669.
20. Grunfeld E, Fitzpatrick R, Mant D, Yudkin P, Adewuyi-Dalton R, Stewart J, Cole D, Vessey M Comparison of breast cancer patient satisfaction with follow-up in primary care versus specialist care: results from a randomized controlled trial. Br J Gen Pract 1999;49:705-710.
21. Grunfeld E, Gray A, Mant D, Yudkin P, Adewuyi-Dalton R, Coyle D, Cole D, Stewart J, Fitzpatrick R, Vessey M. Follow-up of breast cancer in primary care vs specialist care: results of an economic evaluation. Br J Cancer. 1999;79:1227-1233.
22. Grunfeld E, Levine MN, Julian JA, Coyle D, Szechtman B, Mirsky D, Verma S, Dent S, Sawka C, Pritchard KI, Ginsburg D, Wood M, Whelan T. Randomized trial of long-term follow-up for early-stage breast cancer: a comparison of family physician versus specialist care. J Clin Oncol 2006;24:848-855.
23. Pierce JP, Stefanick ML, Flatt SW, Natarajan L, Sternfeld B, Madlensky L, Al-Delaimy WK, Thomson CA, Kealey S, Hajek R, Parker BA, Newman VA, Caan B, Rock CL: Greater survival after breast cancer in physically active women with high vegetable-fruit intake regardless of obesity. J Clin Oncol 2007;25:2345-2351.
24. Newell S, Sanson-Fisher RW, Girgis A, Bonaventura A: How well do medical oncologists' perceptions reflect their patients' reported physical and psychosocial problems? Data from a survey of five oncologists. Cancer. 1998;83:1640-1651.
25. Shimozuma K, Ohashi Y, Takeuchi A, Aranishi T, Morita S, Kuroi K, Ohsumi S, Makino H, Watanabe T, Hausheer F H: Assessment and quantification of taxane-induced neurotoxicity in a phase III randomized trial of breast cancer (AC followed by PAC/DOC vs. PAC/DOC alone): N-SAS BC 02. J Clin Oncol 2006; (18S):8523.
26. Gupta P, Sturdee DW, Palin SL, Majumder K, Fear R, Marshall T, Paterson I: Menopausal symptoms in women treated for breast cancer: the prevalence and severity of symptoms and their perceived effects on quality of life. Climacteric 2006;9:49-58.
27. Tham YL, Sexton K, Weiss HL, Elledge RM, Friedman LC, Kramer RM: The adherence to practice guidelines in the assessment of bone health in women with chemotherapy-induced menopause. J Support Oncol 2006;4:295-298, 304.
28. Earle CC, Neville BA: Under use of necessary care among cancer survivors. Cancer 2004;101:1712-1719.
29. Earle CC, Burstein HJ, Winer EP, Weeks JC: Quality of non-breast cancer health maintenance among elderly breast cancer survivors. J Clin Oncol 2003;21:1447-1451.